Company Filing History:
Years Active: 2015-2018
Title: Simon Hippenmeyer: Innovator in Genetic Engineering
Introduction
Simon Hippenmeyer is a prominent inventor based in Menlo Park, California. He has made significant contributions to the field of genetic engineering, particularly in the area of transgene integration in human cells and mammals. With a total of 2 patents, his work is paving the way for advancements in genetic research and therapeutic applications.
Latest Patents
Hippenmeyer's latest patents include innovative methods for the site-specific integration of transgenes into human cells. One of his patents describes methods for inserting a polynucleotide sequence into the genome of a human cell, specifically targeting the H11 locus. This method not only facilitates the insertion of sequences of interest but also provides nucleic acids that aid in this integration process. Another patent focuses on the site-directed integration of transgenes in mammals, detailing a method for creating transgenic mammals by integrating an intact polynucleotide sequence into a specific genomic locus. This approach ensures that the inserted sequence is transmitted to the progeny of the mammal, thereby enhancing the potential for genetic studies and applications.
Career Highlights
Simon Hippenmeyer is affiliated with Leland Stanford Junior University, where he conducts his research and development in genetic engineering. His work has garnered attention for its potential applications in medicine and biotechnology. His innovative methods are expected to contribute significantly to the understanding of gene function and the development of gene therapies.
Collaborations
Some of his notable coworkers include Ruby Yanru Tsai and Bosiljka Tasic. Their collaborative efforts in research have further advanced the field of genetic engineering.
Conclusion
Simon Hippenmeyer's contributions to genetic engineering through his patents and research at Leland Stanford Junior University highlight his role as a leading innovator in the field. His work continues to inspire advancements in genetic research and therapeutic applications.